GenePOC Inc., has announced its third test to be CE marked - the GenePOC Carba assay, for use with the revogene™ device.

The  GenePOC  Carba  assay  is  a  qualitative,  in  vitro  diagnostic  test  designed  for  the  detection  and  differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like, and blaIMP gene sequences associated with  carbapenem-non-susceptibility. The  assay  can  provide  results  from  one  up  to  eight  samples  in  approximately  70  minutes  using  characterized  carbapenem-non-susceptible  isolated  colonies  of  Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa.

The  revogene  is  an  automated  and  stand-alone  device,  enabling  testing  of  single-use  proprietary  microfluidic  cartridges  with  fluorescence-based  real-time  polymerase  chain  reaction  technology  to  deliver an accurate diagnosis.

Visit www.genepoc-diagnostics.com